Lombard Odier Asset Management (USA)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,000
Closed -$2.74M 243
2018
Q3
$2.74M Sell
10,000
-25,000
-71% -$6.49M 0.2% 139
2018
Q2
$8.33M Buy
+35,000
New +$8.11M 0.54% 49
2015
Q2
Sell
-46,523
Closed -$7.43M 196
2015
Q1
$7.18M Buy
+46,523
New +$6.62M 0.57% 56
2014
Q4
Sell
-79,948
Closed -$9.56M 202
2014
Q3
$9.56M Buy
+79,948
New +$9.17M 0.66% 44

Other funds holding ELV

Lombard Odier Asset Management (USA)'s ELV Position: Q4 2018 in Review

Lombard Odier Asset Management (USA) sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 10,000 shares — an estimated $2.74M sold.

Lombard Odier Asset Management (USA) first reported a position in ELV in Q3 2014 and held it in 4 quarters. The position peaked at $9.56M in Q3 2014. 998 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Lombard Odier Asset Management (USA) reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 10,000 Elevance Health shares in Q4 2018, an estimated $2.74M.
  • Lombard Odier Asset Management (USA) first reported a position in Elevance Health in Q3 2014 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Elevance Health position peaked at $9.56M in Q3 2014.
  • 998 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2018, filed 14 Feb 2019.